Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer.

Sofie H Tolmeijer,Sandra van Wilpe,Maartje J Geerlings,Daniel von Rhein,Tineke J Smilde,Iris S H Kloots,Harm Westdorp,Mustafa Coskuntürk,Irma M Oving,Jolique A van Ipenburg,Antoine G van der Heijden,Tom Hofste,Marjan M Weiss,Jack A Schalken,Winald R Gerritsen,Marjolijn J L Ligtenberg,Niven Mehra

European urology oncology（2023）

引用 0|浏览16

暂无评分

摘要

Benefit from immunotherapy can be predicted after only 3 wk of treatment by investigating cancer DNA in blood. This could help in timely therapy changes for urothelial cancer patients with limited benefit from immunotherapy.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要